Three things to know:
1. Dr. Kelly specializes in nonsurgical spine care and has served as director of the spine center at Atlanta-based Resurgens Orthopaedics since 2007.
2. Since 2017, he has operated as a director at CytoDyn and will continue his role as chairman of the board.
3. CytoDyn is enrolling patients in two COVID-19 clinical trials: one for people with mild-to-moderate symptoms and another for those in critical condition.
More articles on devices:
COVID-19 eases telemedicine’s shackles, expansion looks bright for orthopedics
Life Spine, Northern Light Health & more: 5 spine, orthopedic partnerships in the past month
Spinal robotics market to hit $320M by 2026: 3 updates
